Nanobiotix - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeNanobiotix
Nanobiotix logo

Nanobiotix

0 followers

NBTX

Performance

About Nanobiotix

Nanobiotix is a biotechnology company focused on discovering, developing, manufacturing, and commercializing physics-based nanomedicines for cancer therapy. The company specializes in leveraging nanomaterials to enhance radiotherapy and oncology treatments, aiming to improve patient outcomes across international markets. With research and operations spanning global locations, Nanobiotix positions itself at the intersection of nanomedicine and cancer biology, pursuing novel approaches to treatment. The organization emphasizes scientific innovation, clinical development, and partnerships across the biopharma ecosystem.

Recent News

Recent Deals

No recent deals for this company.

Key Team Members

Anne-Sophie Larivière

Vice President, Strategy & Operational Excellence

Brandon Owens

Vice President, Strategic Marketing and Corporate Communications

Louis Kayitalire, MD

Chief Medical Officer

Anne-Juliette Hermant

Chief People Officer

Laurent Levy, PhD

Chief Executive Officer

Key Facts

HQ Location

Paris, France

Founded

2003

Employees

51 - 200

Status

Public

Website

https://nanobiotix.com